Terms: = Endocrine gland cancer AND JAK2, ENSG00000096968, O60674, JTK10, 3717 AND Treatment
63 results:
1. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
Guan HR; Li B; Zhang ZH; Wu HS; He XL; Dong YJ; Su J; Lv GY; Chen SH
BMC Complement Med Ther; 2023 Dec; 23(1):458. PubMed ID: 38102584
[TBL] [Abstract] [Full Text] [Related]
2. 3'-Hydroxypterostilbene Potently Suppresses Tumor Growth via Inhibiting the Activation of the jak2/STAT3 Pathway in Ovarian Clear Cell Carcinoma.
Koh YC; Huang WZ; Nagabhushanam K; Ho CT; Pan MH
Mol Nutr Food Res; 2024 Jan; 68(1):e2300108. PubMed ID: 37876143
[TBL] [Abstract] [Full Text] [Related]
3. Homoharringtonine sensitizes pancreatic cancer to erlotinib by direct targeting and miRNA-130b-3p-mediated EphB4-jak2-STAT3 axis.
Sarwar A; Zhu Z; Zhu M; Tang X; Su Q; Yang T; Tang W; Zhang Y
J Pharm Pharmacol; 2023 Oct; 75(10):1294-1309. PubMed ID: 37463100
[TBL] [Abstract] [Full Text] [Related]
4. BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.
Huang C; Li H; Xu Y; Xu C; Sun H; Li Z; Ge Y; Wang H; Zhao T; Gao S; Wang X; Yang S; Sun P; Liu Z; Liu J; Chang A; Hao J
Signal Transduct Target Ther; 2023 Jul; 8(1):271. PubMed ID: 37443111
[TBL] [Abstract] [Full Text] [Related]
5. A hybrid nanopharmaceutical for specific-amplifying oxidative stress to initiate a cascade of catalytic therapy for pancreatic cancer.
Liu F; Xiang Q; Luo Y; Luo Y; Luo W; Xie Q; Fan J; Ran H; Wang Z; Sun Y
J Nanobiotechnology; 2023 May; 21(1):165. PubMed ID: 37221521
[TBL] [Abstract] [Full Text] [Related]
6. Ginkgetin suppresses ovarian cancer growth through inhibition of jak2/STAT3 and MAPKs signaling pathways.
Wu L; Qian C; Zhang W; Shi M; Chen X; Wang Y; Lin F
Phytomedicine; 2023 Jul; 116():154846. PubMed ID: 37172479
[TBL] [Abstract] [Full Text] [Related]
7. Mebendazole Impedes the Proliferation and Migration of Pancreatic cancer Cells through SK1 Inhibition Dependent Pathway.
Limbu KR; Chhetri RB; Oh YS; Baek DJ; Park EY
Molecules; 2022 Nov; 27(23):. PubMed ID: 36500220
[TBL] [Abstract] [Full Text] [Related]
8. Hyperandrogenism due to ovarian Leydig cell tumour presenting with polycythaemia.
Demir AY; Blok BB; Brinkhuis EA; Oldenburg-Ligtenberg CP
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35840164
[TBL] [Abstract] [Full Text] [Related]
9. Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating jak2/STAT3 signaling.
Liu W; Wang X; Wang L; Mei Y; Yun Y; Yao X; Chen Q; Zhou J; Kou B
Int J Med Sci; 2022; 19(6):965-974. PubMed ID: 35813296
[TBL] [Abstract] [Full Text] [Related]
10. PARP Inhibitor Upregulates PD-L1 Expression and Provides a New Combination Therapy in Pancreatic cancer.
Wang Y; Zheng K; Xiong H; Huang Y; Chen X; Zhou Y; Qin W; Su J; Chen R; Qiu H; Yuan X; Wang Y; Zou Y
Front Immunol; 2021; 12():762989. PubMed ID: 34975854
[TBL] [Abstract] [Full Text] [Related]
11. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian cancer.
Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
[TBL] [Abstract] [Full Text] [Related]
12. Fisetin inhibits the proliferation, migration and invasion of pancreatic cancer by targeting PI3K/AKT/mTOR signaling.
Xiao Y; Liu Y; Gao Z; Li X; Weng M; Shi C; Wang C; Sun L
Aging (Albany NY); 2021 Nov; 13(22):24753-24767. PubMed ID: 34821587
[TBL] [Abstract] [Full Text] [Related]
13. Inhibition of jak2/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer.
Fan X; Fu H; Xie N; Guo H; Fu T; Shan Y
Aging (Albany NY); 2021 Oct; 13(19):22830-22842. PubMed ID: 34623971
[TBL] [Abstract] [Full Text] [Related]
14. Curcumin inhibits proliferation and invasion of papillary thyroid carcinoma cells by inhibiting the jak2 / STAT3 pathway.
Hu Y; Zhou N; Zhu Q
J BUON; 2021; 26(4):1635-1641. PubMed ID: 34565029
[TBL] [Abstract] [Full Text] [Related]
15. SENP1-mediated deSUMOylation of jak2 regulates its kinase activity and platinum drug resistance.
Li J; Wu R; Yung MMH; Sun J; Li Z; Yang H; Zhang Y; Liu SS; Cheung ANY; Ngan HYS; Braisted JC; Zheng W; Wei H; Gao Y; Nemes P; Pei H; Chan DW; Li Y; Zhu W
Cell Death Dis; 2021 Apr; 12(4):341. PubMed ID: 33795649
[TBL] [Abstract] [Full Text] [Related]
16. Triptolide inhibits jak2/STAT3 signaling and induces lethal autophagy through ROS generation in cisplatin‑resistant SKOV3/DDP ovarian cancer cells.
Zhong Y; Le F; Cheng J; Luo C; Zhang X; Wu X; Xu F; Zuo Q; Tan B
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760192
[TBL] [Abstract] [Full Text] [Related]
17. LDL cholesterol promotes the proliferation of prostate and pancreatic cancer cells by activating the STAT3 pathway.
Jung YY; Ko JH; Um JY; Chinnathambi A; Alharbi SA; Sethi G; Ahn KS
J Cell Physiol; 2021 Jul; 236(7):5253-5264. PubMed ID: 33368314
[TBL] [Abstract] [Full Text] [Related]
18. Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas.
Xiao Z; Yang X; Zhang K; Liu Z; Shao Z; Song C; Wang X; Li Z
Int J Med Sci; 2020; 17(18):3174-3189. PubMed ID: 33173437
[TBL] [Abstract] [Full Text] [Related]
19. Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53.
Liu X; Zhang L; Thu PM; Min W; Yang P; Li J; Li P; Xu X
Sci China Life Sci; 2021 Aug; 64(8):1295-1310. PubMed ID: 33165811
[TBL] [Abstract] [Full Text] [Related]
20. Pimozide augments bromocriptine lethality in prolactinoma cells and in a xenograft model via the STAT5/cyclin D1 and STAT5/Bcl‑xL signaling pathways.
Xiao Z; Liang J; Deng Q; Song C; Yang X; Liu Z; Shao Z; Zhang K; Wang X; Li Z
Int J Mol Med; 2021 Jan; 47(1):113-124. PubMed ID: 33155660
[TBL] [Abstract] [Full Text] [Related]
[Next]